A Agilent Technologies
- 154.230
- -0.080-0.05%
- 154.220
- -0.010-0.01%
Agilent Technologies News
Agilent to Participate in Jefferies Global Healthcare Conference
Agilent Technologies Inc. (NYSE:A) today announced that CFO Bob McMahon will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City on Wednesday, June 5, at 8:30 a.m. EDT. Those
NYSE New 52-Week Highs And Lows
New Highs 188 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ Aflac AFL 86.78 127,615
What's in Store for Applied Materials (AMAT) in Q2 Earnings?
UBS: Maintaining the Clearway Energy (CWEN/A.US) rating, adjusted from buy to buy rating, and adjusted the target price from $32.00 to $33.00.
UBS: Maintaining the Clearway Energy (CWEN/A.US) rating, adjusted from buy to buy rating, and adjusted the target price from $32.00 to $33.00.
US Stock Nuggets | Demand for AI continues to be booming! TSMC and ARM increased by about 5%; the earnings season was full of profit effects! A number of high-performing stocks all recorded double-digit gains
As tech giants accelerate the pace of building AI data centers, demand for electricity continues to rise. NRG Energy, the largest green power company in the US, rose by more than 2% to a record high, and has risen nearly 64% during the year.
Sea Limited (SE) to Report Q1 Earnings: What's in Store?
Agilent on Track for Highest Close Since February 2023 -- Data Talk
Agilent Technologies, Inc. (A) is currently at $149.96, up $4.82 or 3.32% --Would be highest close since Feb. 15, 2023, when it closed at $151.75 --On pace for largest percent increase since April 2
Agilent Has New CEO With Padraig McDonnell
Possible Bearish Signals With Agilent Technologies Insiders Disposing Stock
In the last year, many Agilent Technologies, Inc. (NYSE:A) insiders sold a substantial stake in the company which may have sparked shareholders' attention.
$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today
Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 2.75% on an annualized basis producing an average annual return of 13.25%.
9 Out of 12 S&P500 Materials Stocks Deliver EPS Wins This Week: Earnings Scorecard
Companion Diagnostics Technologies and Global Markets Report 2023-2024 and 2028 Featuring Major Players - F. Hoffmann-La Roche, Agilent Technologies, and QIAGEN - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Companion Diagnostics: Technologies and Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering.The global market for companion diagnostics is estim
Agilent Technologies Appoints Padraig McDonnell as New CEO
Press Release: Agilent to Announce Second-Quarter Fiscal Year 2024 Financial Results May 29
Agilent to Announce Second-Quarter Fiscal Year 2024 Financial Results May 29 SANTA CLARA, Calif.--(BUSINESS WIRE)--May 02, 2024-- Agilent Technologies Inc. (NYSE: A) will release financial results f
Street Color: Agilent Technologies Appoints Padraig McDonnell CEO
(Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is
Agilent: Padraig McDonnell Has Assumed Role of CEO, Effective Immediately >A
Agilent: Padraig McDonnell Has Assumed Role of CEO, Effective Immediately >A
Padraig McDonnell Assumes Agilent CEO Role >A
Padraig McDonnell Assumes Agilent CEO Role >A
Agilent: Mike McMullen Will Serve as an Adviser Until He Retires Oct. 31 >A
Agilent: Mike McMullen Will Serve as an Adviser Until He Retires Oct. 31 >A
Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cytometry Solution
Latest addition to the NovoCyte family celebrates a decade of flow cytometry excellence Agilent Technologies Inc. (NYSE:A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a
How Is The Market Feeling About Agilent Technologies?
Agilent Technologies's (NYSE:A) short percent of float has risen 10.14% since its last report. The company recently reported that it has 3.95 million shares sold short, which is 1.52% of all regular s
Analysis
Price Target
No Data
